David C. Pratt Cancer Center

St Louis, Missouri 63141

0 studies enrolling now · 6 studies all time

What they study most

Early Breast Cancer, HER2-positive Advanced Solid Tumor, Locally Advanced or Unresectable Metastatic Breast Cancer, Ovarian Cancer, Ovarian Granulosa Cell Tumor, Ovarian Granulosa-Stromal Tumor, Prostate Cancer, Stage IV Breast Cancer, Urinary Bladder Neoplasms

Studies at this site

• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors — Recruiting now
• Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC — Running, not enrolling
• A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder — Completed
• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• Nirogacestat in Ovarian Granulosa Cell Tumors — Completed
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling